KIAII, BOB
for the TIGHT K investigators
3 papers on CoChat
Most cited papers
- Verified
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
Anand, S. S., Bosch, J., Eikelboom, J. W., Connolly, S. J., Diaz, R., Widimsky, P., Aboyans, V., Alings, M., Kakkar, A. K., Keltai, K., et al. (2018) · The Lancet
Antiplatelet Therapy and Cardiovascular DiseasesPeripheral Artery Disease Management
Cited by 879
- Verified
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
Connolly, S. J., Eikelboom, J. W., Bosch, J., Dagenais, G., Dyal, L., Lanas, F., Metsarinne, K., O'Donnell, M., Dans, A. L., Ha, J.-W., et al. (2018) · The Lancet
Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research
Cited by 754
- Verified
Potassium Supplementation and Prevention of Atrial Fibrillation After Cardiac Surgery: The TIGHT K Randomized Clinical Trial
O’Brien, B., Campbell, N. G., Allen, E., Jamal, Z., Sturgess, J., Sanders, J., Opondo, C., Roberts, N., Aron, J., Maccaroni, M. R., et al. (2024) · JAMA
Atrial Fibrillation Management and OutcomesCardiac, Anesthesia and Surgical Outcomes
Cited by 36
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free